Navigation Links
BioMarin Announces Third Quarter 2010 Financial Results
Date:10/28/2010

30, 2010 and a negative $1.4 million impact on Naglazyme sales in the nine months ended September 30, 2010.  Naglazyme revenues experience quarterly fluctuations due to the timing of distributor purchases in certain countries due to government ordering patterns. (2)

The quantity of commercial tablets dispensed to patients in the U.S., increased 3.7 percent in the third quarter of 2010 compared to the second quarter of 2010 and increased 29.7 percent in the third quarter of 2010 compared to the third quarter of 2009.(3)

A product for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS) which was launched in the EU in April 2010.Three Months Ended September 30, Nine Months Ended September 30,20092010$ Change% Change 20092010$ Change% Change Aldurazyme revenue reported by Genzyme (4) $

40.3$

40.8$

0.51.2%$

116.4$

124.3$

7.96.8%Royalties due from Genzyme15.916.50.646.050.24.2Incremental (previously recognized) Aldurazyme product transfer revenue(1.3)-1.37.4(2.0)(9.4)Total Aldurazyme net product revenues (5)$

14.6$

16.5$

1.9$

53.4$

48.2$

(5.2)(1)

Changes in foreign currency rates caused a decrease to Aldurazyme sales by Genzyme of $1.5 million in the three months ended September 30, 2010 and a decrease to Aldurazyme sales by Genzyme of $0.6 million for the nine months ended September 30, 2010.  In the third quarter of 2010, the number of Aldurazyme vials shipped increased 5.1 percent over the third quarter of 2009.(2)  

To the extent units shipped to third party customers by Genzyme exceed BioMarin inventory transfers to Genzyme, BioMarin records a decrease in net product revenue from the royalty payable to BioMarin for the amount of previously recognized product transfer revenue.  If BioMarin inventory transfers exceed units shipped to third party customers by Genzyme, BioMarin will record incremental net product  transf
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. BioMarin to Host a Research and Development Day on October 19th
2. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
3. BioMarin to Present at the UBS Global Life Sciences Conference
4. BioMarin to Present at the Stifel Nicolaus Healthcare Conference
5. BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
6. BioMarin Acquires ZyStor Therapeutics, Inc.
7. BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
8. BioMarin to Acquire LEAD Therapeutics
9. BioMarin to Present at the Credit Suisse Healthcare Conference
10. BioMarin Announces Third Quarter 2009 Financial Results
11. BioMarin to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... NEW YORK , March 27, 2015 ... ), the leading source of health information, ... on the new National Action Plan ... interview, President Obama emphasized the urgency and ... impact on national and global health.    ...
(Date:3/26/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... therapies for cardiovascular disease and overall health, announced that ... of the Corporation (the "Common Shares"). The Common Shares ... 5 th , 2014 to March 4 th , ... on or before April 1, 2015. Interest on the ...
(Date:3/26/2015)... "Whether it,s our family, our friends, all ... In a single sentence, Dr. Anthony Coyle , ... Centers for Therapeutic Innovation (CTI), sums up ... America,s biopharmaceutical companies. CTI,s unique model ... foundations and the National Institutes of Health (NIH) to ...
Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
... , BOZEMAN, Mont., Sept 8 ... its third human clinical trial of its norovirus vaccine. ... with LigoCyte,s investigational, nasally-delivered, dry powder vaccine in healthy adults. ... of norovirus infection by including a live virus challenge of ...
... , MORGANTON, W.Va., Sept. 4 People with chronic ... and depression than people treated conventionally for back pain, a West ... , , The three-year, $400,000 study, published in ... pain and improved function in the group that did yoga postures ...
Cached Medicine Technology:LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 2LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 3Yoga Benefits Back-Pain Patients 2
(Date:3/28/2015)... March 28, 2015 Take a bite ... kicks into action. Acids tumble into the stomach, ready ... faulty valve-like structure lets these acids run amok, triggering ... extremely common symptom. More than 60 million Americans have ... examine where heartburn starts, and how it can be ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Thousands ... devices manufactured by C.R. Bard, Inc. continue to ... U.S. District Court, Southern District of West Virginia, ... serving on the Plaintiffs’ Steering Committee. According ... has granted certain defendants named in those lawsuits ...
(Date:3/28/2015)... Emergency Medical Care (EMC), a New ... recently commemorated its three-year anniversary of being the only ... to 24-hour urgent care, Emergency Medical Care offers its ... time, Emergency Medical Care’s Urgent Care NYC ... eye injuries, ear infections, fevers, insect bites, burns, animal ...
(Date:3/28/2015)... New York, NY (PRWEB) March 28, 2015 ... 2015 highlighted a problem which could prove critical to ... Why system testing, a critical aspect of data security, ... payment card industry data security report, every major category ... vulnerability scanning and penetration testing. “With all the craziness ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Pitching speed, player’s ... history of shoulder and elbow injuries, according to new research ... ( AOSSM ) Specialty Day. , “Our findings indicate that ... 20% increase in likelihood of a history of injury, a ... a 12% increase likelihood of a history of injury, and ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2
... for Brain Research in Frankfurt and at The Field Museum ... fruit bats (flying foxes) possess cones in addition to rods. ... cells, the cones for daylight vision and colour vision, and ... bats were traditionally believed to possess only rods. Hence, fruit ...
... years or more of oral steroid treatment decreases the risk ... effects were found regardless of when in the course of ... effects were not observed if the steroids were taken for ... cons of corticosteroid treatment in rheumatoid arthritis have been a ...
... an overhaul in the process used to inspect and ... ,Last fall, grocers and shoppers were in a panic ... contaminated bagged spinach. Nationwide there were 204 illnesses, 104 ... ,The FDA concluded it could not definitively determine how ...
... Ginza district Friday as they urged a boycott of ... ,Walking arm-in-arm, three women walked up to the ... wearing nothing but a banner reading: "The naked truth: ... of the protest by People for the Ethical Treatment ...
... of the public health system in the US keeps tumbling ... stated that adults// with serious mental illness and treated in ... ,The gap has widened since the early '90s ... 15 years. ,"We're going in the wrong direction ...
... headway in the development of an investigative blood test ... complications in the bone marrow, leading to life threatening ... Medical Research Institute (MMRI) and Sydney's West mead Hospital ... blood test to detect such tendencies. ...
Cached Medicine News:Health News:Research on Fruit Bats 2Health News:Research on Fruit Bats 3Health News:Long-term Oral Steroid Therapy Decreases Lymphoma Risk in Rheumatoid Arthritis 2Health News:FDAs Failure Urges It to Reassess Its Policies 2Health News:Major Mental Disorders Cut Life Span by Ten to Fifteen Years 2
... Endo-Surgery provides clip appliers in 10mm and ... appliers provide precise clip placement., ,The ... These preloaded, single-trigger instruments are designed to ... a 5mm trocar, through a 5mm reducer ...
... and IMMULITE 1000 assays are ... IMMULITE and IMMULITE 1000, continuous ... offer simplicity in both design ... be found in a wide ...
The C-Reactive Protein (CRP) assay is used for the quantitative analysis of C-reactive protein in human serum and plasma. Kit is for use with the Abbot Laboratories Aeroset, ARCHITECT c8000 or ARCHI...
... new windows for the laboratory in flexibility, ... move from one function to another. You ... and add a new patient record simultaneously. ... track of all the open functions and ...
Medicine Products: